Evaluation and management of non-alcoholic steatohepatitis

Journal of Hepatology

Volumn 42, Issue SUPPL. 1, 2005, Pages

  Ramesh, Seela ^a   Sanyal, Arun J ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ALANINE AMINOTRANSFERASE; ALPHA TOCOPHEROL; ANTILIPEMIC AGENT; ASCORBIC ACID; ASPARTATE AMINOTRANSFERASE; BETAINE; FIBRIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METFORMIN; PENTOXIFYLLINE; PIOGLITAZONE; ROSIGLITAZONE; S ADENOSYLMETHIONINE; SILYMARIN; URSODEOXYCHOLIC ACID;

ABETALIPOPROTEINEMIA; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANGIOMA; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; AUTOIMMUNE HEPATITIS; CHRONIC FATIGUE SYNDROME; CHRONIC INFLAMMATION; CLINICAL FEATURE; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; HEMOCHROMATOSIS; HEPATOMEGALY; HIGH RISK PATIENT; HIV ASSOCIATED LIPODYSTROPHY; HUMAN; HYPOBETALIPOPROTEINEMIA; INTESTINE DIVERTICULOSIS; LIVER BIOPSY; LIVER FIBROSIS; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; PORTAL HYPERTENSION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SHORT BOWEL SYNDROME; TOTAL PARENTERAL NUTRITION; VIRUS HEPATITIS; WEBER CHRISTIAN PANNICULITIS;

EID: 14944386870     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2004.11.022     Document Type: Review

References (67)

1. M.J. Contos, and A.J. Sanyal The clinicopathologic spectrum and management of nonalcoholic fatty liver disease Adv Anat Pathol 9 2002 37 51
2. J.M. Clark, F.L. Brancati, and A.M. Diehl The prevalence and etiology of elevated aminotransferase levels in the United States Am J Gastroenterol 98 2003 960 967
3. Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Circulation 2002;106:3143-3421.
4. A.J. Sanyal, C. Campbell-Sargent, F. Mirshahi, W.B. Rizzo, M.J. Contos, and R.K. Sterling Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities Gastroenterology 120 2001 1183 1192
5. S. Chitturi, and G.C. Farrell Etiopathogenesis of nonalcoholic steatohepatitis Semin Liver Dis 21 2001 27 41
6. E.S. Ford, W.H. Giles, and W.H. Dietz Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey JAMA 287 2002 356 359
7. K.M. Flegal, M.D. Carroll, C.L. Ogden, and C.L. Johnson Prevalence and trends in obesity among US adults, 1999-2000 JAMA 288 2002 1723 1727
8. M. Haque, and A.J. Sanyal The metabolic abnormalities associated with non-alcoholic fatty liver disease Best Pract Res Clin Gastroenterol 16 2002 709 731
9. M.M. Skelly, P.D. James, and S.D. Ryder Findings on liver biopsy to investigate abnormal liver function tests in the absence of diagnostic serology J Hepatol 35 2001 195 199
10. U.L. Mathiesen, L.E. Franzen, A. Fryden, U. Foberg, and G. Bodemar The clinical significance of slightly to moderately increased liver transaminase values in asymptomatic patients Scand J Gastroenterol 34 1999 85 91
11. J. Choudhury, and A.J. Sanyal Insulin resistance and the pathogenesis of nonalcoholic fatty liver disease Clin Liver Dis 8 2004 575 594
12. R.A. De Fronzo, and E. Ferrannini Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease Diab Care 14 1991 173 194
13. A.M. Diehl Fatty liver, hypertension, and the metabolic syndrome Gut 53 2004 923 924
14. G. Marchesini, E. Bugianesi, G. Forlani, F. Cerrelli, M. Lenzi, and R. Manini Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome Hepatology 37 2003 917 923
15. J.M. Clark, and A.M. Diehl Hepatic steatosis and type 2 diabetes mellitus Curr Diab Rep 2 2002 210 215
16. Y. Falck-Ytter, Z.M. Younossi, G. Marchesini, and A.J. McCullough Clinical features and natural history of nonalcoholic steatosis syndromes Semin Liver Dis 21 2001 17 26
17. W. Youssef, and A.J. McCullough Diabetes mellitus, obesity, and hepatic steatosis Semin Gastrointest Dis 13 2002 17 30
18. B.A. Neuschwander-Tetri, and B.R. Bacon Nonalcoholic steatohepatitis Med Clin North Am 80 1996 1147 1166
19. D.L. Haller, C. Sargeant, V.A. Luketic, and A.J. Sanyal A behavioral analysis of nonalcoholic fatty liver disease Hepatology 38 2003 233A
20. B.R. Bacon, M.J. Farahvash, C.G. Janney, and B.A. Neuschwander-Tetri Nonalcoholic steatohepatitis: an expanded clinical entity Gastroenterology 107 1994 1103 1109
21. J. Ludwig, T.R. Viggiano, D.B. McGill, and B.J. Oh Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease Mayo Clin Proc 55 1980 434 438
22. E.E. Powell, W.G. Cooksley, R. Hanson, J. Searle, J.W. Halliday, and L.W. Powell The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years Hepatology 11 1990 74 80
23. A.D. Clouston, and E.E. Powell Interaction of non-alcoholic fatty liver disease with other liver diseases Best Pract Res Clin Gastroenterol 16 2002 767 781
24. C.A. Matteoni, Z.M. Younossi, T. Gramlich, N. Boparai, Y.C. Liu, and A.J. McCullough Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity Gastroenterology 116 1999 1413 1419
25. P. Angulo, J.C. Keach, K.P. Batts, and K.D. Lindor Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis Hepatology 30 1999 1356 1362
26. A.J. Sanyal AGA technical review on nonalcoholic fatty liver disease Gastroenterology 123 2002 1705 1725
27. Y. Yajima, K. Ohta, T. Narui, R. Abe, H. Suzuki, and M. Ohtsuki Ultrasonographical diagnosis of fatty liver: significance of the liver-kidney contrast Tohoku J Exp Med 139 1983 43 50
28. H. Fusamoto, K. Suzuki, N. Hayashi, Y. Sasaki, M. Kono, and A. Kasahara Obesity and liver disease: evaluation of fatty infiltration of the liver using ultrasonic attenuation J Nutr Sci Vitaminol (Tokyo) 37 1991 S71 S77
29. R.G. Lee Nonalcoholic steatohepatitis: a study of 49 patients Hum Pathol 20 1989 594 598
30. S. Saadeh, Z.M. Younossi, E.M. Remer, T. Gramlich, J.P. Ong, and M. Hurley The utility of radiological imaging in nonalcoholic fatty liver disease Gastroenterology 123 2002 745 750
31. J.E. Jacobs, B.A. Birnbaum, M.A. Shapiro, C.P. Langlotz, F. Slosman, and S.E. Rubesin Diagnostic criteria for fatty infiltration of the liver on contrast-enhanced helical CT AJR Am J Roentgenol 171 1998 659 664
32. D. Sorbi, D.B. McGill, J.L. Thistle, T.M. Therneau, J. Henry, and K.D. Lindor An assessment of the role of liver biopsies in asymptomatic patients with chronic liver test abnormalities Am J Gastroenterol 95 2000 3206 3210
33. S.H. Caldwell, D.H. Oelsner, J.C. Iezzoni, E.E. Hespenheide, E.H. Battle, and C.J. Driscoll Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease Hepatology 29 1999 664 669
34. D. Sorbi, J. Boynton, and K.D. Lindor The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease Am J Gastroenterol 94 1999 1018 1022
35. K.O. Lewis, and A. Paton ABC of alcohol: tools of detection Br Med J (Clin Res Ed) 283 1981 1531 1532
36. M. Salaspuro Use of enzymes for the diagnosis of alcohol-related organ damage Enzyme 37 1987 87 107
37. B. Nalpas, A. Vassault, S. Charpin, B. Lacour, and P. Berthelot Serum mitochondrial aspartate aminotransferase as a marker of chronic alcoholism: diagnostic value and interpretation in a liver unit Hepatology 6 1986 608 614
38. E.L. Storey, U. Mack, L.W. Powell, and J.W. Halliday Use of chromatofocusing to detect a transferrin variant in serum of alcoholic subjects Clin Chem 31 1985 1543 1545
39. G. Marchesini, M. Brizi, G. Bianchi, S. Tomassetti, E. Bugianesi, and M. Lenzi Nonalcoholic fatty liver disease: a feature of the metabolic syndrome Diabetes 50 2001 1844 1850
40. A. Garg, and A. Misra Hepatic steatosis, insulin resistance, and adipose tissue disorders J Clin Endocrinol Metab 87 2002 3019 3022
41. A. Garg Lipodystrophies Am J Med 108 2000 143 152
42. Executive summary of the clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. Arch Intern Med 1998;158:1855-1867.
43. G.A. Bray, S.J. Nielsen, and B.M. Popkin Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity Am J Clin Nutr 79 2004 537 543
44. W.R. Archer, B. Lamarche, O. Deriaz, N. Landry, L. Corneau, and J.P. Despres Variations in body composition and plasma lipids in response to a high-carbohydrate diet Obes Res 11 2003 978 986
45. S.B. Sondike, N. Copperman, and M.S. Jacobson Effects of a low-carbohydrate diet on weight loss and cardiovascular risk factor in overweight adolescents J Pediatr 142 2003 253 258
46. K.C. Hayes Saturated fats and blood lipids: new slant on an old story Can J Cardiol 11 1995 39G 46G
47. P.O. Kwiterovich Jr The effect of dietary fat, antioxidants, and pro-oxidants on blood lipids, lipoproteins, and atherosclerosis J Am Diet Assoc 97 1997 S31 S41
48. J.M. Gaziano, and J.E. Manson Diet and heart disease. The role of fat, alcohol, and antioxidants Cardiol Clin 14 1996 69 83
49. W.C. Knowler, E. Barrett-Connor, S.E. Fowler, R.F. Hamman, J.M. Lachin, and E.A. Walker Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin N Engl J Med 346 2002 393 403
50. A. Kriska Can a physically active lifestyle prevent type 2 diabetes? Exerc Sport Sci Rev 31 2003 132 137
51. G. Rollins Moderate exercise reduces the risk of heart disease and death in men with type 2 diabetes Rep Med Guidelines Outcomes Res 14 2003 10 12
52. P. Hollander Orlistat in the treatment of obesity Prim Care 30 2003 427 440
53. R. Holt Orlistat reduces features of the metabolic syndrome: the XENDOS study Diabetes Obes Metab 5 2003 356
54. R. Padwal, S.K. Li, and D.C. Lau Long-term pharmacotherapy for overweight and obesity: a systematic review and meta-analysis of randomized controlled trials Int J Obes Relat Metab Disord 27 2003 1437 1446
55. D.H. Ryan Use of sibutramine to treat obesity Prim Care 30 2003 405 426
56. T. Sabuncu, Y. Nazligul, M. Karaoglanoglu, E. Ucar, and F.B. Kilic The effects of sibutramine and orlistat on the ultrasonographic findings, insulin resistance and liver enzyme levels in obese patients with non-alcoholic steatohepatitis Rom J Gastroenterol 12 2003 189 192
57. F.H. Luyckx, A.J. Scheen, C. Desaive, A. Thiry, and P.J. Lefebvre Parallel reversibility of biological markers of the metabolic syndrome and liver steatosis after gastroplasty-induced weight loss in severe obesity J Clin Endocrinol Metab 84 1999 4293
58. F.H. Luyckx, C. Desaive, A. Thiry, W. Dewe, A.J. Scheen, and J.E. Gielen Liver abnormalities in severely obese subjects: effect of drastic weight loss after gastroplasty Int J Obes Relat Metab Disord 22 1998 222 226
59. S.H. Caldwell, E.E. Hespenheide, J.A. Redick, J.C. Iezzoni, E.H. Battle, and B.L. Sheppard A pilot study of a thiazolidinedione, troglitazone, in nonalcoholic steatohepatitis Am J Gastroenterol 96 2001 519 525
60. B.A. Neuschwander-Tetri, E.M. Brunt, K.R. Wehmeier, D. Oliver, and B.R. Bacon Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-gamma ligand rosiglitazone Hepatology 38 2003 1008 1017
61. G. Marchesini, M. Brizi, G. Bianchi, S. Tomassetti, M. Zoli, and N. Melchionda Metformin in non-alcoholic steatohepatitis Lancet 358 2001 893 894
62. A.J. Sanyal, P. Mofrad, M.J. Contos, C. Sargeant, V.A. Luketic, and R.K. Sterling A pilot study for the treatment of Vitamin E Versus Vitamin E and Pioglitazone for the treatment of NonAlcohol Induced Steatohepatitis C Clin Gastroenterol Hepatol 2004 [in press]
63. P. Angulo Use of ursodeoxycholic acid in patients with liver disease Curr Gastroenterol Rep 4 2002 37 44
64. K.D. Lindor, K.V. Kowdley, E.J. Heathcote, M.E. Harrison, R. Jorgensen, and P. Angulo Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trial Hepatology 39 2004 770 778
65. J.E. Lavine Vitamin E treatment of nonalcoholic steatohepatitis in children: a pilot study J Pediatr 136 2000 734 738
66. P. Vajro, C. Mandato, A. Franzese, E. Ciccimarra, S. Lucariello, and M. Savoia Vitamin E treatment in pediatric obesity-related liver disease: a randomized study J Pediatr Gastroenterol Nutr 38 2004 48 55
67. A.J. Barak, H.C. Beckenhauer, and D.J. Tuma S-adenosylmethionine generation and prevention of alcoholic fatty liver by betaine Alcohol 11 1994 501 503